SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-11-023717
Filing Date
2011-04-20
Accepted
2011-04-20 17:13:02
Documents
1
Period of Report
2011-04-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3127
  Complete submission text file 0001209191-11-023717.txt   4498
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Issuer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 416 MARLBOROUGH STREET APT. 707 BOSTON MA 02115
Business Address
Gillespie Deirdre (Reporting) CIK: 0001354737 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-24274 | Film No.: 11771327